Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Relationships among injury, fibrosis, and time in human kidney transplants
Jeffery M. Venner, Konrad S. Famulski, Jeff Reeve, Jessica Chang, Philip F. Halloran
Jeffery M. Venner, Konrad S. Famulski, Jeff Reeve, Jessica Chang, Philip F. Halloran
View: Text | PDF
Clinical Research and Public Health Inflammation Nephrology

Relationships among injury, fibrosis, and time in human kidney transplants

  • Text
  • PDF
Abstract

BACKGROUND. Kidney transplant biopsies offer an opportunity to understand the pathogenesis of organ fibrosis. We studied the relationships between the time of biopsy after transplant (TxBx), histologic fibrosis, diseases, and transcript expression.

METHODS. Expression microarrays from 681 kidney transplant indication biopsies taken either early (n = 282, <1 year) or late (n = 399, >1 year) after transplant were used to analyze the molecular landscape of fibrosis in relationship to histologic fibrosis and diseases.

RESULTS. Fibrosis was absent at transplantation but was present in some early biopsies by 4 months after transplant, apparently as a self-limited response to donation implantation injury not associated with progression to failure. The molecular phenotype of early biopsies represented the time sequence of the response to wounding: immediate expression of acute kidney injury transcripts, followed by fibrillar collagen transcripts after several weeks, then by the appearance of immunoglobulin and mast cell transcripts after several months as fibrosis appeared. Fibrosis in late biopsies correlated with injury, fibrillar collagen, immunoglobulin, and mast cell transcripts, but these were independent of time. Pathway analysis revealed epithelial response-to-wounding pathways such as Wnt/β-catenin.

CONCLUSION. Fibrosis in late biopsies had different associations because many kidneys had potentially progressive diseases and subsequently failed. Molecular correlations with fibrosis in late biopsies were independent of time, probably because ongoing injury obscured the response-to-wounding time sequence. The results indicate that fibrosis in kidney transplants is driven by nephron injury and that progression to failure reflects continuing injury, not autonomous fibrogenesis.

TRIAL REGISTRATION. INTERCOM study (www.clinicalTrials.gov; NCT01299168).

FUNDING. Canada Foundation for Innovation and Genome Canada.

Authors

Jeffery M. Venner, Konrad S. Famulski, Jeff Reeve, Jessica Chang, Philip F. Halloran

×

Figure 4

The global transcript landscape of atrophy fibrosis in the discovery and validation sets.

Options: View larger image (or click on image) Download as PowerPoint
The global transcript landscape of atrophy fibrosis in the discovery and...
The association strength of all IQR-filtered probe sets to atrophy fibrosis (ci score >1) is shown as P values from the ci score >1 Bayes t test (x axis), with the corresponding fold changes (y axis). We visualized probe sets belonging to the following transcript sets: mast cell (MCATs), red; immunoglobulin (IGTs), blue; acute kidney injury (AKI), green; and fibrillar collagen (FICOL), yellow; and remaining interquartile range–filtered (IQR-filtered) probe sets, gray dots. Each symbol represents an individual probe set. (A) Discovery set biopsies only (n = 401). (B) Validation set biopsies only (n = 280). (C and D) Relationship of P values (Spearman correlation coefficient = 0.51) (C) and fold changes (D) (Spearman correlation coefficient = 0.71) between the discovery and validation sets.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts